Krystal Biotech, Inc. to Present at the 30th Annual ROTH Conference
Mar 05, 2018 13:00 pm UTC| Business
PITTSBURGH, March 05, 2018 -- Krystal Biotech, Inc. (NASDAQ:KRYS), a gene therapy company advancing “off-the-shelf,” treatments for dermatological diseases, today announced that Krish Krishnan, Chief Executive Officer,...
Mar 05, 2018 12:59 pm UTC| Business
Company expects to discontinue the programConference call and webcast today at 8:30 a.m. ET / 5:30 a.m. PT MENLO PARK, Calif., March 05, 2018 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated...
Mar 05, 2018 12:55 pm UTC| Business
NEW YORK, March 05, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Yum! Brands, Inc....
Mar 05, 2018 12:50 pm UTC| Business
NEW YORK, March 05, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of KalVista...
Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018
Mar 05, 2018 12:50 pm UTC| Business
FRAMINGHAM, Mass., March 05, 2018 -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company...
Mar 05, 2018 12:45 pm UTC| Business
NEW YORK, March 05, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Box, Inc....
Aeterna Zentaris Provides Update on Previously Disclosed Class Action Lawsuit
Mar 05, 2018 12:45 pm UTC| Business
CHARLESTON, S.C., March 05, 2018 -- Aeterna Zentaris Inc. (the “Company” or “Aeterna Zentaris”) (NASDAQ:AEZS) and (TSX:AEZS) announced today that the United States District Court for the District of New Jersey has...